<DOC>
	<DOCNO>NCT02141815</DOCNO>
	<brief_summary>Chronic kidney disease associate accumulation various metabolite , i.e. , uremic retention solute . Evidence mount colonic microbiota contributes substantially uremic retention solute . Indoxyl sulfate p-cresyl sulfate among extensively study gut microbial metabolite , associate cardiovascular disease , overall mortality chronic kidney disease progression . The important regulator colonic bacterial metabolism nutrient availability especially ratio available fermentable carbohydrate nitrogen , modify intake so-called prebiotics ( non-digestible food ingredient ) . Arabinoxylan oligosaccharides ( AXOS ) recently develop group prebiotics , already demonstrate decrease effect intestinal generation p-cresol healthy individual . Whether prebiotics general , AXOS specifically , influence intestinal generation microbial metabolite predialysis patient studied date . An interventional study AXOS therefore initiate test hypothesis AXOS decrease intestinal generation serum concentration microbial metabolite patient CKD yet dialysis .</brief_summary>
	<brief_title>The Effect Arabinoxylan-oligosaccharides ( AXOS ) Intestinal Generation Microbial Metabolites Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Age ≥ 18 ≤ 85 year Chronic kidney disease stage 3b4 , i.e. , estimate glomerular filtration rate ( CKDepi ) 45 15 ml/min/m² 29 Written informed consent History organic gastrointestinal disease ( e.g. , inflammatory bowel disease , malignancy ) History colonic surgery Recipient renal solid organ transplant Use pre/pro/syn antibiotic precede 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>